{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "19415223",
  "DateCompleted": {
    "Year": "2010",
    "Month": "09",
    "Day": "13"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "12",
    "Day": "03"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/978-0-387-78574-5_36"
    ],
    "Journal": {
      "ISSN": "0927-3042",
      "JournalIssue": {
        "Volume": "146",
        "PubDate": {
          "Year": "2009"
        }
      },
      "Title": "Cancer treatment and research",
      "ISOAbbreviation": "Cancer Treat Res"
    },
    "ArticleTitle": "Topical treatment of field cancerization.",
    "Pagination": {
      "StartPage": "439",
      "EndPage": "446",
      "MedlinePgn": "439-46"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Dermatology, Transplant-Aftercare Unit, Charit\u00e9-Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany."
          }
        ],
        "LastName": "Ulrich",
        "ForeName": "Claas",
        "Initials": "C"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cancer Treat Res",
    "NlmUniqueID": "8008541",
    "ISSNLinking": "0927-3042"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Aminoquinolines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunosuppressive Agents"
    },
    {
      "RegistryNumber": "144O8QL0L1",
      "NameOfSubstance": "Diclofenac"
    },
    {
      "RegistryNumber": "P1QW714R7M",
      "NameOfSubstance": "Imiquimod"
    },
    {
      "RegistryNumber": "U3P01618RT",
      "NameOfSubstance": "Fluorouracil"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Aminoquinolines"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Apoptosis"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "Carcinoma, Squamous Cell"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Diclofenac"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Fluorouracil"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Imiquimod"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Immunosuppression Therapy"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Immunosuppressive Agents"
    },
    {
      "QualifierName": [
        "etiology",
        "therapy"
      ],
      "DescriptorName": "Keratosis, Actinic"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Organ Transplantation"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Photochemotherapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Recurrence"
    },
    {
      "QualifierName": [
        "diagnosis",
        "etiology"
      ],
      "DescriptorName": "Skin Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Tissue Distribution"
    }
  ],
  "NumberOfReferences": "35"
}